These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 3573536

  • 21. Plasma kinin concentration in deoxycorticosterone-salt hypertension.
    Nakagawa M, Nasjletti A.
    Hypertension; 1988 May; 11(5):411-5. PubMed ID: 3284820
    [Abstract] [Full Text] [Related]

  • 22. Short and long term effects of antihypertensive therapy in the diabetic rat.
    Anderson S, Rennke HG, Garcia DL, Brenner BM.
    Kidney Int; 1989 Oct; 36(4):526-36. PubMed ID: 2681929
    [Abstract] [Full Text] [Related]

  • 23. The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease.
    Hartner A, Cordasic N, Klanke B, Müller U, Sterzel RB, Hilgers KF.
    Am J Pathol; 2002 Mar; 160(3):861-7. PubMed ID: 11891185
    [Abstract] [Full Text] [Related]

  • 24. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Ueda M, Tatsumi Y, Yoshikawa J.
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [Abstract] [Full Text] [Related]

  • 25. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
    O'Brien RC, Cooper ME, Jerums G, Doyle AE.
    Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
    [Abstract] [Full Text] [Related]

  • 26. Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.
    Velasquez MT, Striffler JS, Abraham AA, Michaelis OE, Scalbert E, Thibault N.
    Hypertension; 1997 Nov; 30(5):1232-7. PubMed ID: 9369281
    [Abstract] [Full Text] [Related]

  • 27. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.
    Anderson S, Rennke HG, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475
    [Abstract] [Full Text] [Related]

  • 28. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a.
    Westhoff JH, Hilgers KF, Steinbach MP, Hartner A, Klanke B, Amann K, Melk A.
    Hypertension; 2008 Jul; 52(1):123-9. PubMed ID: 18504326
    [Abstract] [Full Text] [Related]

  • 29. Effects of antihypertensive drugs on glomerular morphology.
    Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I.
    Kidney Int; 1989 Oct; 36(4):626-35. PubMed ID: 2554053
    [Abstract] [Full Text] [Related]

  • 30. Blood pressure responses to enalapril in rats with one- and two-kidney DOC-NaCl hypertension.
    Arvola P, Nurmi AK, Säynävälammi P, Manninen V, Vapaatalo H.
    Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):67-71. PubMed ID: 2540388
    [Abstract] [Full Text] [Related]

  • 31. The effect of norepinephrine on aortic 42K turnover during deoxycorticosterone acetate hypertension and antihypertensive therapy in the rat.
    Jones AW, Sander PD, Kampschmidt DL.
    Circ Res; 1977 Aug; 41(2):256-60. PubMed ID: 872301
    [Abstract] [Full Text] [Related]

  • 32. Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment.
    Feld LG, Van Liew JB, Brentjens JR, Boylan JW.
    Kidney Int; 1981 Nov; 20(5):606-14. PubMed ID: 7343711
    [Abstract] [Full Text] [Related]

  • 33. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP, Raij L.
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [Abstract] [Full Text] [Related]

  • 34. Deoxycorticosterone hypertension in the intact weanling rat without salt loading.
    Rodriguez-Sargent C, Torres-Negron I, Cangiano JL, Martinez-Maldonado M.
    Hypertension; 1990 Feb; 15(2 Suppl):I112-6. PubMed ID: 2298466
    [Abstract] [Full Text] [Related]

  • 35. Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
    Nicholas TE.
    Br J Pharmacol; 1971 Jun; 42(2):179-92. PubMed ID: 4326321
    [Abstract] [Full Text] [Related]

  • 36. Hormone and electrolyte changes in post-deoxycorticosterone salt hypertension in rats.
    Morton JJ, Kenyon CJ, Beattie EC.
    J Hypertens; 1990 Nov; 8(11):1021-6. PubMed ID: 1963184
    [Abstract] [Full Text] [Related]

  • 37. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK, Padilha RM, Zatz R.
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [Abstract] [Full Text] [Related]

  • 38. Dietary chloride and bicarbonate as determinants of desoxycorticosterone hypertension.
    Kurtz TW, Morris RC.
    J Hypertens Suppl; 1984 Dec; 2(3):S371-3. PubMed ID: 6100744
    [Abstract] [Full Text] [Related]

  • 39. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
    Lafayette RA, Mayer G, Park SK, Meyer TW.
    J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
    [Abstract] [Full Text] [Related]

  • 40. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.
    Anderson S, Diamond JR, Karnovsky MJ, Brenner BM.
    J Clin Invest; 1988 Nov; 82(5):1757-68. PubMed ID: 2846658
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.